0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Specialty Drug Distribution Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-2322
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Specialty Drug Distribution Market Size Status and Forecast 2022
BUY CHAPTERS

Global Specialty Drug Distribution Market Research Report 2025

Code: QYRE-Auto-2322
Report
June 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Specialty Drug Distribution Market Size

The global market for Specialty Drug Distribution was valued at US$ 326854 million in the year 2024 and is projected to reach a revised size of US$ 655326 million by 2031, growing at a CAGR of 10.6% during the forecast period.

Specialty Drug Distribution Market

Specialty Drug Distribution Market

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies. It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization. Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
The specialty drug distribution market is primarily driven by the rising prevalence of chronic and rare diseases such as cancer, multiple sclerosis, and autoimmune disorders, which require high-cost, complex biologics and specialty medications. Additionally, advancements in biotechnology and the increasing number of FDA approvals for specialty drugs have expanded the portfolio of products requiring specialized logistics, cold chain management, and coordinated patient support services—further fueling demand for dedicated distribution systems.
One of the key challenges in specialty drug distribution is the complexity of regulatory compliance and handling requirements. These drugs often require strict temperature control, secure tracking, and adherence to pharmacy benefit management protocols. Moreover, limited distribution networks and high logistical costs can create access barriers for patients, while distributors must balance efficiency, safety, and cost containment in an increasingly competitive and fragmented market landscape.
Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc. North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent. In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.
This report aims to provide a comprehensive presentation of the global market for Specialty Drug Distribution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Specialty Drug Distribution.
The Specialty Drug Distribution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Specialty Drug Distribution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Specialty Drug Distribution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Specialty Drug Distribution Market Report

Report Metric Details
Report Name Specialty Drug Distribution Market
Accounted market size in year US$ 326854 million
Forecasted market size in 2031 US$ 655326 million
CAGR 10.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oncology
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Hemophilia
  • Others
Segment by Application
  • Hospital and Clinic
  • Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AmerisourceBergen, Mckesson, Cardinal Health, Phoenix, Medipal Holdings, Alliance Healthcare, Sinopharm, Express Scripts, Shanghai Pharma, Anda, Jointown, Max Pharma, CR Pharma, Jianzhijia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Specialty Drug Distribution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Specialty Drug Distribution Market growing?

Ans: The Specialty Drug Distribution Market witnessing a CAGR of 10.6% during the forecast period 2025-2031.

What is the Specialty Drug Distribution Market size in 2031?

Ans: The Specialty Drug Distribution Market size in 2031 will be US$ 655326 million.

What is the Specialty Drug Distribution Market share by type?

Ans: In terms of product, Oncology is the largest segment, with a share over 50%.

Who are the main players in the Specialty Drug Distribution Market report?

Ans: The main players in the Specialty Drug Distribution Market are AmerisourceBergen, Mckesson, Cardinal Health, Phoenix, Medipal Holdings, Alliance Healthcare, Sinopharm, Express Scripts, Shanghai Pharma, Anda, Jointown, Max Pharma, CR Pharma, Jianzhijia

What are the Application segmentation covered in the Specialty Drug Distribution Market report?

Ans: The Applications covered in the Specialty Drug Distribution Market report are Hospital and Clinic, Pharmacy, Others

What are the Type segmentation covered in the Specialty Drug Distribution Market report?

Ans: The Types covered in the Specialty Drug Distribution Market report are Oncology, Rheumatoid Arthritis, Multiple Sclerosis, Hemophilia, Others

Recommended Reports

Chronic Disease Therapy

Oncology Solutions

Drug Supply Chain

Market trends :

Topic Trends
Global the specialty drug distribution market is experiencing rapid growth driven by rising prevalence of chronic and rare diseases, increased fda approvals, and demand for advanced cold chain logistics and patient support services.
Type Oncology - oncology remains the largest specialty drug segment, driven by increasing cancer prevalence and new biologic therapies requiring specialized distribution.
Rheumatoid Arthritis - demand for specialty drugs in rheumatoid arthritis is rising due to the growing adoption of advanced biologics and targeted therapies.
Multiple Sclerosis - multiple sclerosis specialty drug distribution is expanding as new therapies and patient support services are introduced.
Hemophilia - hemophilia specialty drug distribution is growing with the introduction of novel treatments and improved cold chain logistics.
Application Hospital and Clinic - hospitals and clinics are the primary channel for specialty drug distribution, reflecting the need for controlled administration and patient monitoring.
Pharmacy - pharmacies are increasingly involved in specialty drug dispensing as distribution networks expand and patient access improves.
Company AmerisourceBergen - amerisourcebergen is expanding its specialty drug distribution network to address increasing demand for oncology and chronic disease therapies.
Mckesson - mckesson is enhancing its specialty pharmaceutical logistics and cold chain capabilities to support the growing complexity of specialty drug distribution.
Cardinal Health - cardinal health is focusing on integrated distribution solutions for specialty drugs, emphasizing regulatory compliance and secure supply chain management.
Phoenix - phoenix is strengthening its european specialty drug distribution footprint to meet rising demand for biologics and complex therapies.
Medipal Holdings - medipal holdings is investing in advanced distribution infrastructure to support specialty drug logistics in the apac region.
Alliance Healthcare - alliance healthcare is expanding specialty drug offerings and distribution services across europe to capture market growth.
Sinopharm - sinopharm is scaling up specialty drug distribution channels in china to address increasing demand for oncology and autoimmune therapies.
Express Scripts - express scripts is leveraging pharmacy benefit management to improve specialty drug utilization tracking and patient access.
Shanghai Pharma - shanghai pharma is enhancing specialty drug logistics and distribution networks to support growth in the chinese healthcare market.
Anda - anda is expanding its specialty pharmaceutical distribution services to meet the needs of independent pharmacies and clinics.
Jointown - jointown is investing in cold chain and specialty drug distribution infrastructure to support the growing chinese market.
Max Pharma - max pharma is focusing on specialty drug distribution expansion in emerging markets to capture new growth opportunities.
CR Pharma - cr pharma is strengthening its specialty drug supply chain and distribution capabilities to support rising demand in china.
Jianzhijia - jianzhijia is expanding specialty drug distribution services to improve access for hospitals and clinics in china.
Region North America - north america leads the specialty drug distribution market, driven by high prevalence of chronic diseases and advanced healthcare infrastructure.
EMEA - emea is experiencing growth in specialty drug distribution due to increased adoption of biologics and regulatory harmonization.
APAC - apac specialty drug distribution is expanding rapidly, fueled by rising healthcare investment and demand for advanced therapies.
LATAM - latam is seeing increased specialty drug distribution activity as access to innovative therapies improves and healthcare systems modernize.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specialty Drug Distribution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oncology
1.2.3 Rheumatoid Arthritis
1.2.4 Multiple Sclerosis
1.2.5 Hemophilia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Specialty Drug Distribution Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Specialty Drug Distribution Market Perspective (2020-2031)
2.2 Global Specialty Drug Distribution Growth Trends by Region
2.2.1 Global Specialty Drug Distribution Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Specialty Drug Distribution Historic Market Size by Region (2020-2025)
2.2.3 Specialty Drug Distribution Forecasted Market Size by Region (2026-2031)
2.3 Specialty Drug Distribution Market Dynamics
2.3.1 Specialty Drug Distribution Industry Trends
2.3.2 Specialty Drug Distribution Market Drivers
2.3.3 Specialty Drug Distribution Market Challenges
2.3.4 Specialty Drug Distribution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Specialty Drug Distribution Players by Revenue
3.1.1 Global Top Specialty Drug Distribution Players by Revenue (2020-2025)
3.1.2 Global Specialty Drug Distribution Revenue Market Share by Players (2020-2025)
3.2 Global Top Specialty Drug Distribution Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Specialty Drug Distribution Revenue
3.4 Global Specialty Drug Distribution Market Concentration Ratio
3.4.1 Global Specialty Drug Distribution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specialty Drug Distribution Revenue in 2024
3.5 Global Key Players of Specialty Drug Distribution Head office and Area Served
3.6 Global Key Players of Specialty Drug Distribution, Product and Application
3.7 Global Key Players of Specialty Drug Distribution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Specialty Drug Distribution Breakdown Data by Type
4.1 Global Specialty Drug Distribution Historic Market Size by Type (2020-2025)
4.2 Global Specialty Drug Distribution Forecasted Market Size by Type (2026-2031)
5 Specialty Drug Distribution Breakdown Data by Application
5.1 Global Specialty Drug Distribution Historic Market Size by Application (2020-2025)
5.2 Global Specialty Drug Distribution Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Specialty Drug Distribution Market Size (2020-2031)
6.2 North America Specialty Drug Distribution Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Specialty Drug Distribution Market Size by Country (2020-2025)
6.4 North America Specialty Drug Distribution Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Specialty Drug Distribution Market Size (2020-2031)
7.2 Europe Specialty Drug Distribution Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Specialty Drug Distribution Market Size by Country (2020-2025)
7.4 Europe Specialty Drug Distribution Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Specialty Drug Distribution Market Size (2020-2031)
8.2 Asia-Pacific Specialty Drug Distribution Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Specialty Drug Distribution Market Size by Region (2020-2025)
8.4 Asia-Pacific Specialty Drug Distribution Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Specialty Drug Distribution Market Size (2020-2031)
9.2 Latin America Specialty Drug Distribution Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Specialty Drug Distribution Market Size by Country (2020-2025)
9.4 Latin America Specialty Drug Distribution Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Specialty Drug Distribution Market Size (2020-2031)
10.2 Middle East & Africa Specialty Drug Distribution Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Specialty Drug Distribution Market Size by Country (2020-2025)
10.4 Middle East & Africa Specialty Drug Distribution Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AmerisourceBergen
11.1.1 AmerisourceBergen Company Details
11.1.2 AmerisourceBergen Business Overview
11.1.3 AmerisourceBergen Specialty Drug Distribution Introduction
11.1.4 AmerisourceBergen Revenue in Specialty Drug Distribution Business (2020-2025)
11.1.5 AmerisourceBergen Recent Development
11.2 Mckesson
11.2.1 Mckesson Company Details
11.2.2 Mckesson Business Overview
11.2.3 Mckesson Specialty Drug Distribution Introduction
11.2.4 Mckesson Revenue in Specialty Drug Distribution Business (2020-2025)
11.2.5 Mckesson Recent Development
11.3 Cardinal Health
11.3.1 Cardinal Health Company Details
11.3.2 Cardinal Health Business Overview
11.3.3 Cardinal Health Specialty Drug Distribution Introduction
11.3.4 Cardinal Health Revenue in Specialty Drug Distribution Business (2020-2025)
11.3.5 Cardinal Health Recent Development
11.4 Phoenix
11.4.1 Phoenix Company Details
11.4.2 Phoenix Business Overview
11.4.3 Phoenix Specialty Drug Distribution Introduction
11.4.4 Phoenix Revenue in Specialty Drug Distribution Business (2020-2025)
11.4.5 Phoenix Recent Development
11.5 Medipal Holdings
11.5.1 Medipal Holdings Company Details
11.5.2 Medipal Holdings Business Overview
11.5.3 Medipal Holdings Specialty Drug Distribution Introduction
11.5.4 Medipal Holdings Revenue in Specialty Drug Distribution Business (2020-2025)
11.5.5 Medipal Holdings Recent Development
11.6 Alliance Healthcare
11.6.1 Alliance Healthcare Company Details
11.6.2 Alliance Healthcare Business Overview
11.6.3 Alliance Healthcare Specialty Drug Distribution Introduction
11.6.4 Alliance Healthcare Revenue in Specialty Drug Distribution Business (2020-2025)
11.6.5 Alliance Healthcare Recent Development
11.7 Sinopharm
11.7.1 Sinopharm Company Details
11.7.2 Sinopharm Business Overview
11.7.3 Sinopharm Specialty Drug Distribution Introduction
11.7.4 Sinopharm Revenue in Specialty Drug Distribution Business (2020-2025)
11.7.5 Sinopharm Recent Development
11.8 Express Scripts
11.8.1 Express Scripts Company Details
11.8.2 Express Scripts Business Overview
11.8.3 Express Scripts Specialty Drug Distribution Introduction
11.8.4 Express Scripts Revenue in Specialty Drug Distribution Business (2020-2025)
11.8.5 Express Scripts Recent Development
11.9 Shanghai Pharma
11.9.1 Shanghai Pharma Company Details
11.9.2 Shanghai Pharma Business Overview
11.9.3 Shanghai Pharma Specialty Drug Distribution Introduction
11.9.4 Shanghai Pharma Revenue in Specialty Drug Distribution Business (2020-2025)
11.9.5 Shanghai Pharma Recent Development
11.10 Anda
11.10.1 Anda Company Details
11.10.2 Anda Business Overview
11.10.3 Anda Specialty Drug Distribution Introduction
11.10.4 Anda Revenue in Specialty Drug Distribution Business (2020-2025)
11.10.5 Anda Recent Development
11.11 Jointown
11.11.1 Jointown Company Details
11.11.2 Jointown Business Overview
11.11.3 Jointown Specialty Drug Distribution Introduction
11.11.4 Jointown Revenue in Specialty Drug Distribution Business (2020-2025)
11.11.5 Jointown Recent Development
11.12 Max Pharma
11.12.1 Max Pharma Company Details
11.12.2 Max Pharma Business Overview
11.12.3 Max Pharma Specialty Drug Distribution Introduction
11.12.4 Max Pharma Revenue in Specialty Drug Distribution Business (2020-2025)
11.12.5 Max Pharma Recent Development
11.13 CR Pharma
11.13.1 CR Pharma Company Details
11.13.2 CR Pharma Business Overview
11.13.3 CR Pharma Specialty Drug Distribution Introduction
11.13.4 CR Pharma Revenue in Specialty Drug Distribution Business (2020-2025)
11.13.5 CR Pharma Recent Development
11.14 Jointown
11.14.1 Jointown Company Details
11.14.2 Jointown Business Overview
11.14.3 Jointown Specialty Drug Distribution Introduction
11.14.4 Jointown Revenue in Specialty Drug Distribution Business (2020-2025)
11.14.5 Jointown Recent Development
11.15 Jianzhijia
11.15.1 Jianzhijia Company Details
11.15.2 Jianzhijia Business Overview
11.15.3 Jianzhijia Specialty Drug Distribution Introduction
11.15.4 Jianzhijia Revenue in Specialty Drug Distribution Business (2020-2025)
11.15.5 Jianzhijia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Specialty Drug Distribution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oncology
 Table 3. Key Players of Rheumatoid Arthritis
 Table 4. Key Players of Multiple Sclerosis
 Table 5. Key Players of Hemophilia
 Table 6. Key Players of Others
 Table 7. Global Specialty Drug Distribution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Specialty Drug Distribution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Specialty Drug Distribution Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Specialty Drug Distribution Market Share by Region (2020-2025)
 Table 11. Global Specialty Drug Distribution Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Specialty Drug Distribution Market Share by Region (2026-2031)
 Table 13. Specialty Drug Distribution Market Trends
 Table 14. Specialty Drug Distribution Market Drivers
 Table 15. Specialty Drug Distribution Market Challenges
 Table 16. Specialty Drug Distribution Market Restraints
 Table 17. Global Specialty Drug Distribution Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Specialty Drug Distribution Market Share by Players (2020-2025)
 Table 19. Global Top Specialty Drug Distribution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Drug Distribution as of 2024)
 Table 20. Ranking of Global Top Specialty Drug Distribution Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Specialty Drug Distribution Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Specialty Drug Distribution, Headquarters and Area Served
 Table 23. Global Key Players of Specialty Drug Distribution, Product and Application
 Table 24. Global Key Players of Specialty Drug Distribution, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Specialty Drug Distribution Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Specialty Drug Distribution Revenue Market Share by Type (2020-2025)
 Table 28. Global Specialty Drug Distribution Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Specialty Drug Distribution Revenue Market Share by Type (2026-2031)
 Table 30. Global Specialty Drug Distribution Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Specialty Drug Distribution Revenue Market Share by Application (2020-2025)
 Table 32. Global Specialty Drug Distribution Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Specialty Drug Distribution Revenue Market Share by Application (2026-2031)
 Table 34. North America Specialty Drug Distribution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Specialty Drug Distribution Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Specialty Drug Distribution Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Specialty Drug Distribution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Specialty Drug Distribution Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Specialty Drug Distribution Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Specialty Drug Distribution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Specialty Drug Distribution Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Specialty Drug Distribution Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Specialty Drug Distribution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Specialty Drug Distribution Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Specialty Drug Distribution Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Specialty Drug Distribution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Specialty Drug Distribution Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Specialty Drug Distribution Market Size by Country (2026-2031) & (US$ Million)
 Table 49. AmerisourceBergen Company Details
 Table 50. AmerisourceBergen Business Overview
 Table 51. AmerisourceBergen Specialty Drug Distribution Product
 Table 52. AmerisourceBergen Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 53. AmerisourceBergen Recent Development
 Table 54. Mckesson Company Details
 Table 55. Mckesson Business Overview
 Table 56. Mckesson Specialty Drug Distribution Product
 Table 57. Mckesson Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 58. Mckesson Recent Development
 Table 59. Cardinal Health Company Details
 Table 60. Cardinal Health Business Overview
 Table 61. Cardinal Health Specialty Drug Distribution Product
 Table 62. Cardinal Health Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 63. Cardinal Health Recent Development
 Table 64. Phoenix Company Details
 Table 65. Phoenix Business Overview
 Table 66. Phoenix Specialty Drug Distribution Product
 Table 67. Phoenix Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 68. Phoenix Recent Development
 Table 69. Medipal Holdings Company Details
 Table 70. Medipal Holdings Business Overview
 Table 71. Medipal Holdings Specialty Drug Distribution Product
 Table 72. Medipal Holdings Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 73. Medipal Holdings Recent Development
 Table 74. Alliance Healthcare Company Details
 Table 75. Alliance Healthcare Business Overview
 Table 76. Alliance Healthcare Specialty Drug Distribution Product
 Table 77. Alliance Healthcare Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 78. Alliance Healthcare Recent Development
 Table 79. Sinopharm Company Details
 Table 80. Sinopharm Business Overview
 Table 81. Sinopharm Specialty Drug Distribution Product
 Table 82. Sinopharm Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 83. Sinopharm Recent Development
 Table 84. Express Scripts Company Details
 Table 85. Express Scripts Business Overview
 Table 86. Express Scripts Specialty Drug Distribution Product
 Table 87. Express Scripts Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 88. Express Scripts Recent Development
 Table 89. Shanghai Pharma Company Details
 Table 90. Shanghai Pharma Business Overview
 Table 91. Shanghai Pharma Specialty Drug Distribution Product
 Table 92. Shanghai Pharma Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 93. Shanghai Pharma Recent Development
 Table 94. Anda Company Details
 Table 95. Anda Business Overview
 Table 96. Anda Specialty Drug Distribution Product
 Table 97. Anda Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 98. Anda Recent Development
 Table 99. Jointown Company Details
 Table 100. Jointown Business Overview
 Table 101. Jointown Specialty Drug Distribution Product
 Table 102. Jointown Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 103. Jointown Recent Development
 Table 104. Max Pharma Company Details
 Table 105. Max Pharma Business Overview
 Table 106. Max Pharma Specialty Drug Distribution Product
 Table 107. Max Pharma Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 108. Max Pharma Recent Development
 Table 109. CR Pharma Company Details
 Table 110. CR Pharma Business Overview
 Table 111. CR Pharma Specialty Drug Distribution Product
 Table 112. CR Pharma Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 113. CR Pharma Recent Development
 Table 114. Jointown Company Details
 Table 115. Jointown Business Overview
 Table 116. Jointown Specialty Drug Distribution Product
 Table 117. Jointown Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 118. Jointown Recent Development
 Table 119. Jianzhijia Company Details
 Table 120. Jianzhijia Business Overview
 Table 121. Jianzhijia Specialty Drug Distribution Product
 Table 122. Jianzhijia Revenue in Specialty Drug Distribution Business (2020-2025) & (US$ Million)
 Table 123. Jianzhijia Recent Development
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources
 Table 127. Authors List of This Report


List of Figures
 Figure 1. Specialty Drug Distribution Picture
 Figure 2. Global Specialty Drug Distribution Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Specialty Drug Distribution Market Share by Type: 2024 VS 2031
 Figure 4. Oncology Features
 Figure 5. Rheumatoid Arthritis Features
 Figure 6. Multiple Sclerosis Features
 Figure 7. Hemophilia Features
 Figure 8. Others Features
 Figure 9. Global Specialty Drug Distribution Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Specialty Drug Distribution Market Share by Application: 2024 VS 2031
 Figure 11. Hospital and Clinic Case Studies
 Figure 12. Pharmacy Case Studies
 Figure 13. Others Case Studies
 Figure 14. Specialty Drug Distribution Report Years Considered
 Figure 15. Global Specialty Drug Distribution Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Specialty Drug Distribution Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Specialty Drug Distribution Market Share by Region: 2024 VS 2031
 Figure 18. Global Specialty Drug Distribution Market Share by Players in 2024
 Figure 19. Global Specialty Drug Distribution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Specialty Drug Distribution Revenue in 2024
 Figure 21. North America Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Specialty Drug Distribution Market Share by Country (2020-2031)
 Figure 23. United States Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Specialty Drug Distribution Market Share by Country (2020-2031)
 Figure 27. Germany Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Ireland Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Specialty Drug Distribution Market Share by Region (2020-2031)
 Figure 35. China Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia & New Zealand Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Specialty Drug Distribution Market Share by Country (2020-2031)
 Figure 43. Mexico Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Specialty Drug Distribution Market Share by Country (2020-2031)
 Figure 47. Israel Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Specialty Drug Distribution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. AmerisourceBergen Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 51. Mckesson Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 52. Cardinal Health Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 53. Phoenix Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 54. Medipal Holdings Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 55. Alliance Healthcare Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 56. Sinopharm Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 57. Express Scripts Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 58. Shanghai Pharma Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 59. Anda Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 60. Jointown Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 61. Max Pharma Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 62. CR Pharma Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 63. Jointown Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 64. Jianzhijia Revenue Growth Rate in Specialty Drug Distribution Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD